Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease

American Heart Journal

Volumn 153, Issue 6, 2007, Pages 1064-1073

  Berger, Alan K ^a   Duval, Sue ^a   Manske, Connie ^a   Vazquez, Gabriela ^a   Barber, Cheryl ^a   Miller, Leslie ^a   Luepker, Russell V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYRALAZINE; INOTROPIC AGENT; NITRATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART; HOSPITAL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATHEROSCLEROSIS; CHRONIC DISEASE; COMORBIDITY; DRUG UTILIZATION; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MINNESOTA; RECEPTORS, ANGIOTENSIN; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34249683835     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.017     Document Type: Article

References (35)

1. American Heart Association. Heart disease and stroke statistics-2005 update (2005), American Heart Association, Dallas
2. The SOLVD Investigattors. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
4. AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342 (1993) 821-828
5. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
6. Rector T.S., Johnson G., Dunkman W.B., et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993) VI71-VI77
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
8. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor trials. JAMA 273 (1995) 1450-1456
9. Pitt B., Segal R., Martinez F.A., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349 (1997) 747-752
10. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
11. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
12. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
13. Bonow R.O., Bennett S., Casey Jr. D.E., et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop heart failure clinical performance measures): endorsed by the Heart Failure Society of America. Circulation 112 (2005) 1853-1887
14. ADHERE Registry Collaborators. ADHERE Registry. 2nd Quarter 2003 Benchmark Report. Subset analysis: treatment of acute heart failure patients with renal insufficiency (Cr >2.0 mg/dL) (2005), Scios, Inc. www.adhereregistry.com
15. Shahar E., Lee S., Kim J., et al. Hospitalized heart failure: rates and long-term mortality. J Card Fail 10 (2004) 374-379
16. Abbott R., and McGee D. The Framingham Study: an epidemiological investigation of cardiovascular disease, section 37 (1987), National Heart, Lung, and Blood Institute, Bethesda (MD)
17. Kannel W.B., D'Agostino R.B., Silbershatz H., et al. Profile for estimating risk of heart failure. Arch Intern Med 159 (1999) 1197-1204
18. K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease Work Group and Evidence Review Team Membership. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl 1 (2002) S1-S266
19. Sprafka J., Virnig B., Shahar E., et al. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabet Med 11 (1994) 678-684
20. McAlister F., Ezekowitz J., Tonelli M., et al. Renal insufficiency and heart failure. Prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
21. Dries D., Exner D., Domanski M., et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
22. Shlipak M.G. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138 (2003) 917-924
23. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
24. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
25. Bakris G., and Weir M. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?. Arch Intern Med 160 (2003) 685-693
26. Philbin E.F., Santella R.N., and Rocco Jr. T.A. Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. J Am Geriatr Soc 47 (1999) 302-308
27. Hou F.F., Zhang X., Zhang G.H., et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354 (2006) 131-140
28. McCullough P.A., Sandberg K.R., Yee J., et al. Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease. J Renin Angiotensin Aldosterone Syst 3 (2002) 188-191
29. Trespalacios F.C., Taylor A.J., Agodoa L.Y., et al. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis 41 (2003) 1267-1277
30. Harnett J.D., Foley R.N., Kent G.M., et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47 (1995) 884-890
31. Stack A.G., and Bloembergen W.E. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 38 (2001) 992-1000
32. Aoki J., Ikari Y., Nakajima H., et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 67 (2005) 333-340
33. Steiner J.F., Robbins L.J., Hammermeister K.E., et al. Incidence of digoxin toxicity in outpatients. West J Med 161 (1994) 474-478
34. Giles T.D., Katz R., Sullivan J.M., et al. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. J Am Coll Cardiol 13 (1989) 1240-1247
35. Burnier M., Waeber B., Nussberger J., et al. Effect of angiotensin converting enzyme inhibition in renovascular hypertension. J Hypertens Suppl 7 (1989) S27-S31